• 1
    Reimann HA. Periodic disease. Medicine (Baltimore) 1951;30:219245.
  • 2
    Dinarello CA, Gelfand JA. Harrison′s Principles of Internal Medicine. New York: McGraw-Hill Publ. Co., 1998; 8490.
  • 3
    Kluger MJ, Bartfai T, Dinarello CA. New York Academy of Sciences & Lovelace Respiratory Research Institute. Molecular Mechanisms of Fever. New York Academy of Sciences, 1998.
  • 4
    Knockaert DC. Recurrent fevers of unknown origin. Infect Dis Clin North Am 2007;21:11891211.
  • 5
    Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell 2010;140:784790.
  • 6
    Ryan ME, Ferrigno K, O'Boyle T, Long SS. Periodic fever and skin lesions caused by disseminated Mycobacterium chelonae infection in an immunocompetent child. Pediatr Infect Dis J 1996;15:270272.
  • 7
    Lekstrom-Himes JA, Dale JK, Kingma DW, Diaz PS, Jaffe ES, Straus SE. Periodic illness associated with Epstein–Barr virus infection. Clin Infect Dis 1996;22:2227.
  • 8
    Cogswell FB. The hypnozoite and relapse in primate malaria. Clin Microbiol Rev 1992;5:2635.
  • 9
    Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009;124:11611178.
  • 10
    Grüber C, Keil T, Kulig M, Roll S, Wahn U, Wahn V. History of respiratory infections in the first 12 yr among children from a birth cohort. Pediatr Allergy Immunol 2008;19:505512.
  • 11
    Johnson M. Neoplastic fever. Palliat Med 1996;10:217224.
  • 12
    Kurzrock R. Cytokine deregulation in cancer. Biomed Pharmacother 2001;55:543547.
  • 13
    Henderson C, Goldbach-Mansky R. Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis. Curr Opin Rheumatol 2010;22:567578.
  • 14
    Gattorno M, Federici S, Pelagatti MA, Caorsi R, Brisca G, Malattia C et al. Diagnosis and management of autoinflammatory diseases in childhood. J Clin Immunol 2008;28(Suppl 1):S73S83.
  • 15
    Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 2009;27:621668.
  • 16
    Kallinich T, Keitzer R, Puskas E, Boldt F. Exercise-induced hyperthermia in childhood: a case report and pilot study. Acta Paediatr 2009;98:12171219.
  • 17
    Trejo-Hernandez J, Loredo-Abdala A, Orozco-Garibay JM. Munchausen syndrome by proxy in Mexican children: medical, social, psychological and legal aspects. Rev Invest Clin 2011;63:253262.
  • 18
    Zenone T. Fever of unknown origin in adults: evaluation of 144 cases in a non-university hospital. Scand J Infect Dis 2006;38:632638.
  • 19
    Roush MK, Nelson KM. Understanding drug-induced febrile reactions. Am Pharm 1993;33:3942.
  • 20
    Patel RA, Gallagher JC. Drug fever. Pharmacotherapy 2010;30:5769.
  • 21
    de Kleijn EM, van Lier HJ, van der Meer JW. Fever of unknown origin (FUO) II. Diagnostic procedures in a prospective multicenter study of 167 patients. The Netherlands FUO Study Group. Medicine (Baltimore) 1997;76:401414.
  • 22
    Bleeker-Rovers CP, Vos FJ, de Kleijn EM, Mudde AH, Dofferhoff TS, Richter C et al. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore) 2007;86:2638.
  • 23
    Gathmann B, Grimbacher B, Beauté J, Dudoit Y, Mahlaoui N, Fischer A et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol 2009;157(Suppl 1):311.
  • 24
    Magnani C, Gatta G, Corazziari I, Kramarova E, Pastore G, Viscomi S et al. Childhood malignancies in the EUROCARE study: the database and the methods of survival analysis. Eur J Cancer 2001;37:678686.
  • 25
    Robert Koch-Institut. Zentrum für Krebsregisterdaten, Krebs in Deutschland 2007/2008., 2012.
  • 26
    Kümpfel T, Hoffmann LA, Rübsamen H, Pöllmann W, Feneberg W, Hohlfeld R et al. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation. Arthritis Rheum 2007;56:27742783.
  • 27
    Tamir N, Langevitz P, Zemer D, Pras E, Shinar Y, Padeh S et al. Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics. Am J Med Genet 1999;87:3035.
  • 28
    Savage T, Loftus BG, Tormey V, McDermott MF, Moylett E. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) or familial Hibernian fever: presentation in a four-day-old infant. J Clin Rheumatol 2008;14:342345.
  • 29
    Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 2002;81:349368.
  • 30
    Leslie KS, Lachmann HJ, Bruning E, McGrath JA, Bybee A, Gallimore JR et al. Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations. Arch Dermatol 2006;142:15911597.
  • 31
    Dale DC, Hammond WPT. Cyclic neutropenia: a clinical review. Blood Rev 1988;2:178185.
  • 32
    Dale DC, Bolyard AA, Aprikyan A. Cyclic neutropenia. Semin Hematol 2002;39:8994.
  • 33
    Thomas KT, Feder HM Jr, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr 1999;135:1521.
  • 34
    Padeh S, Brezniak N, Zemer D, Pras E, Livneh A, Langevitz P et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 1999;135:98101.
  • 35
    Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R et al. Familial Mediterranean fever at the millennium clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore) 1998;77:268297.
  • 36
    Hoffman HM, Wanderer AA, Broide DH. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 2001;108:615620.
  • 37
    Stych B, Dobrovolny D. Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives. Curr Med Res Opin 2008;24:15771582.
  • 38
    Muckle TJ, Wells M. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med 1962;31:235248.
  • 39
    van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 2008;87:301310.
  • 40
    Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a periodic fever syndrome). Acta Paediatr 2010;99:178184.
  • 41
    de Koning HD, Bodar EJ, van der Meer JW, Simon A. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 2007;37:137148.
  • 42
    Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:18791885.
  • 43
    Drenth JP, Haagsma CJ, van der Meer JW. Hyperimmunoglobulinemia D and periodic fever syndrome the clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 1994;73:133144.
  • 44
    Wurster VM, Carlucci JG, Feder HM Jr, Edwards KM. Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. J Pediatr 2011;159:958964.
  • 45
    Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967;43:227253.
  • 46
    Akar S, Soyturk M, Onen F, Tunca M. The relations between attacks and menstrual periods and pregnancies of familial Mediterranean fever patients. Rheumatol Int 2006;26:676679.
  • 47
    Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, van Amstel HK et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum 2003;48:26322644.
  • 48
    Stojanov S, Lapidus S, Chitkara P, Feder H, Salazar JC, Fleisher TA et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci USA 2011;108:71487153.
  • 49
    Padeh S, Livneh A, Pras E, Shinar Y, Lidar M, Feld O et al. Familial Mediterranean fever in the first two years of life: a unique phenotype of disease in evolution. J Pediatr 2010;156:985989.
  • 50
    Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 2001;69:301314.
  • 51
    Muckle TJ. The ‘Muckle–Wells’ syndrome. Br J Dermatol 1979;100:8792.
  • 52
    Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 2007;119:e474e483.
  • 53
    Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006;355:581592.
  • 54
    Bodar EJ, Kuijk LM, Drenth JP, van der Meer JW, Simon A, Frenkel J. On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis 2011;70:21552158.
  • 55
    Gattorno M, Pelagatti MA, Meini A, Obici L, Barcellona R, Federici S et al. Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 2008;58:15161520.
  • 56
    Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G et al. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean Fever: a randomized trial. Ann Internal Med 2012;157:533541.
  • 57
    Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998;351:659664.
  • 58
    Stewart L, Tolmie J, Galea P, Touitou I. Familial Mediterranean fever in a cold climate: read The Lancet. Lancet 2000;356:2154.
  • 59
    Tchernitchko DO, Gérard-Blanluet M, Legendre M, Cazeneuve C, Grateau G, Amselem S. Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever. Ann Rheum Dis 2006;65:11541157.
  • 60
    Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002;46:33403348.
  • 61
    Lachmann HJ, Sengül B, Yavuzşen TU, Booth DR, Booth SE, Bybee A et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006;45:746750.
  • 62
    Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002;61:7981.
  • 63
    Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 2011;7:105112.
  • 64
    Yoshihara T, Imamura T, Yokoi K, Shibata M, Kano G, Osone S et al. Potential use of procalcitonin concentrations as a diagnostic marker of the PFAPA syndrome. Eur J Pediatr 2007;166:621622.
  • 65
    Yüksel S, Ekim M, Ozçakar ZB, Yalçınkaya F, Acar B, Oztuna D et al. The value of procalcitonin measurements in children with familial Mediterranean fever. Rheumatol Int 2011; [Epub ahead of print].
  • 66
    Wittkowski H, Kuemmerle-Deschner JB, Austermann J, Holzinger D, Goldbach-Mansky R, Gramlich K et al. MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes. Ann Rheum Dis 2011;70:20752081.
  • 67
    Kallinich T, Wittkowski H, Keitzer R, Roth J, Foell D. Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever. Ann Rheum Dis 2010;69:677682.
  • 68
    Medlej-Hashim M, Petit I, Adib S, Chouery E, Salem N, Delague V et al. Familial Mediterranean fever: association of elevated IgD plasma levels with specific MEFV mutations. Eur J Hum Genet 2001;9:849854.
  • 69
    Gattorno M, Tassi S, Carta S, Delfino L, Ferlito F, Pelagatti MA et al. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum 2007;56:31383148.
  • 70
    McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:133144.
  • 71
    Gattorno M, Sormani MP, D'Osualdo A, Pelagatti MA, Caroli F, Federici S et al. A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum 2008;58:18231832.
  • 72
    Padeh S, Shinar Y, Pras E, Zemer D, Langevitz P, Pras M et al. Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever. J Rheumatol 2003;30:185190.
  • 73
    Cazeneuve C, Hovannesyan Z, Geneviève D, Hayrapetyan H, Papin S, Girodon-Boulandet E et al. Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum 2003;48:23242331.
  • 74
    Koné-Paut I, Hentgen V, Guillaume-Czitrom S, Compeyrot-Lacassagne S, Tran TA, Touitou I. The clinical spectrum of 94 patients carrying a single mutated MEFV allele. Rheumatology (Oxford) 2009;48:840842.
  • 75
    Kogan A, Shinar Y, Lidar M, Revivo A, Langevitz P, Padeh S et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001;102:272276.
  • 76
    Camus D, Shinar Y, Aamar S, Langevitz P, Ben-Zvi I, Livneh A et al. ‘Silent’ carriage of two familial Mediterranean fever gene mutations in large families with only a single identified patient. Clin Genet 2011;82:288291.
  • 77
    Marek-Yagel D, Bar-Joseph I, Pras E, Berkun Y. Is E148Q a benign polymorphism or a disease-causing mutation? J Rheumatol 2009;36:2372.
  • 78
    Cazeneuve C, Sarkisian T, Pêcheux C, Dervichian M, Nédelec B, Reinert P et al. MEFV-gene analysis in Armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 1999;65:8897.
  • 79
    Aksentijevich I, D Putnam C, Remmers EF, Mueller JL, Le J, Kolodner RD et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum 2007;56:12731285.
  • 80
    Pelagatti MA, Meini A, Caorsi R, Cattalini M, Federici S et al. Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. Arthritis Rheum 2011;63:11411150.
  • 81
    Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome International Hyper-IgD Study Group. Nat Genet 1999;22:178181.
  • 82
    Simon A, Cuisset L, Vincent MF, van Der Velde-Visser SD, Delpech M, van Der Meer JW et al. Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-Igd and periodic fever syndrome: its application as a diagnostic tool. Ann Intern Med 2001;135:338343.
  • 83
    Liu Y, Ramot Y, Torrelo A, Paller AS, Si N, Babay S et al. Mutations in PSMB8 cause CANDLE syndrome with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 2011;64:895907.
  • 84
    Torrelo A, Patel S, Colmenero I, Gurbindo D, Lendínez F, Hernández A et al. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol 2010;62:489495.
  • 85
    Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 2011;365:620628.
  • 86
    Augey F, Renaudier P, Nicolas JF. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol 2006;16:669673.
  • 87
    Zelickson BD, Muller SA. Generalized pustular psoriasis. A review of 63 cases. Arch Dermatol 1991;127:13391345.
  • 88
    Ohkawara A, Yasuda H, Kobayashi H, Inaba Y, Ogawa H, Hashimoto I et al. Generalized pustular psoriasis in Japan: two distinct groups formed by differences in symptoms and genetic background. Acta Derm Venereol 1996;76:6871.
  • 89
    Borghini S, Tassi S, Chiesa S, Caroli F, Carta S, Caorsi R et al. Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation. Arthritis Rheum 2011;63:830839.
  • 90
    Jéru I, Duquesnoy P, Fernandes-Alnemri T, Cochet E, Yu JW, Lackmy-Port-Lis M et al. Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci USA 2008;105:16141619.